Article
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2
17 Jun 2020
Abstract excerpt
The emergence of a new coronavirus in Wuhan China has triggered a global need for accurate diagnostic assays. Initially, mostly laboratory developed molecular tests were available but shortly thereafter different commercial assays started to appear and are still increasing in number. Although independent performance evaluations are ongoing, available data is still scarce. Here we provide a direct comparison of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
